Product Information
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.6645 per EA under NDC 42571013360. Its NADAC has been published 243 times since Feb 9, 2022.
FDA first approved this application on Jul 15, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 200 mg/1; ug/1
Manufacturer
Micro Labs LimitedNDC
42571013360
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
Generic (ANDA)
FDA Application
ANDA204355FDA Approved
7/15/2021
TE Code
AB
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has been published 243 times since Feb 9, 2022, and over the history we have for it it has declined 53.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6645 per EA |
|---|---|
| All-time high | $1.5755 (Apr 10, 2024) |
| All-time low | $0.6645 (Sep 23, 2026) |
| 52-week high | $1.0044 |
| 52-week low | $0.6645 |
| Median price | $0.9944 |
| Average price | $1.0434 |
| Largest weekly change | +59.0% (Mar 20, 2024) |
| Weeks tracked | 243 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac Sodium/Misoprostol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Sodium/Misoprostol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET, manufactured by Micro Labs Limited, is $0.6645 per EA (NDC 42571013360), effective Sep 30, 2026.
How has the price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has declined 53.4%. It has been tracked across 243 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
Since Feb 9, 2022, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has ranged from a low of $0.6645 (Sep 23, 2026) to a high of $1.5755 (Apr 10, 2024), with a median of $0.9944 per EA.
Are there cheaper alternatives to DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET (NDC 42571013360) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.